Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma ; volume:21 ; number:1 ; day:19 ; month:4 ; year:2021 ; pages:1-12 ; date:12.2021
Cancer cell international ; 21, Heft 1 (19.4.2021), 1-12, 12.2021
- Urheber
-
Jou, Yeong-Chin
Lin, Guan-Ling
Lin, Hon-Yi
Huang, Wan-Hong
Chuang, Yu-Ming
Lin, Ru-Inn
Chen, Pie-Che
Wu, Shu-Fen
Shen, Cheng-Huang
Chan, Michael W. Y.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-021-01925-9
- URN
-
urn:nbn:de:101:1-2021060612545642964096
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jou, Yeong-Chin
- Lin, Guan-Ling
- Lin, Hon-Yi
- Huang, Wan-Hong
- Chuang, Yu-Ming
- Lin, Ru-Inn
- Chen, Pie-Che
- Wu, Shu-Fen
- Shen, Cheng-Huang
- Chan, Michael W. Y.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Combined epigenetic/genetic study identified an ALS age of onset modifier
The epigenetic modifier Fam208a is required to maintain epiblast cell fitness
Lineage-specific regulation of epigenetic modifier genes in human liver and brain
Oocyte TET3: an epigenetic modifier responsible for maternal inheritance of glucose intolerance
Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma
Targeting the epigenetic modifier HDAC6 for cancer therapy and for overcoming drug resistance
Author Correction: The epigenetic modifier Fam208a is required to maintain epiblast cell fitness
The fusiform gyrus exhibits an epigenetic signature for Alzheimer’s disease
Epigenetic engineering and the art of epigenetic manipulation
Epigenetic modifier alpha-ketoglutarate modulates aberrant gene body methylation and hydroxymethylation marks in diabetic heart
Epigenetic drug discovery
Obesity: epigenetic aspects
Combined epigenetic/genetic study identified an ALS age of onset modifier
The epigenetic modifier Fam208a is required to maintain epiblast cell fitness
Lineage-specific regulation of epigenetic modifier genes in human liver and brain
Oocyte TET3: an epigenetic modifier responsible for maternal inheritance of glucose intolerance
Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma
Targeting the epigenetic modifier HDAC6 for cancer therapy and for overcoming drug resistance
Author Correction: The epigenetic modifier Fam208a is required to maintain epiblast cell fitness
The fusiform gyrus exhibits an epigenetic signature for Alzheimer’s disease
Epigenetic engineering and the art of epigenetic manipulation
Epigenetic modifier alpha-ketoglutarate modulates aberrant gene body methylation and hydroxymethylation marks in diabetic heart
Epigenetic drug discovery
Obesity: epigenetic aspects
Combined epigenetic/genetic study identified an ALS age of onset modifier
The epigenetic modifier Fam208a is required to maintain epiblast cell fitness
Lineage-specific regulation of epigenetic modifier genes in human liver and brain
Oocyte TET3: an epigenetic modifier responsible for maternal inheritance of glucose intolerance
Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma
Targeting the epigenetic modifier HDAC6 for cancer therapy and for overcoming drug resistance
Author Correction: The epigenetic modifier Fam208a is required to maintain epiblast cell fitness
The fusiform gyrus exhibits an epigenetic signature for Alzheimer’s disease
Epigenetic engineering and the art of epigenetic manipulation
Epigenetic modifier alpha-ketoglutarate modulates aberrant gene body methylation and hydroxymethylation marks in diabetic heart
Epigenetic drug discovery